+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global AI-Enabled Medical Imaging Solutions Market: 15 Countries Analysis - Analysis and Forecast, 2020-2030

  • ID: 5237667
  • Report
  • December 2020
  • Region: Global
  • BIS Research
Global AI-Enabled Medical Imaging Solutions Market to Reach $10.15 Billion by 2030

FEATURED COMPANIES

  • Agfa-Gevaert Group
  • Arterys Inc.
  • General Electric Company
  • Hyperfine
  • Koninklije Philips N.V.
  • Nanox
  • MORE

Market Report Coverage - AI-Enabled Medical Imaging Solutions

Market Segmentation

  • Therapeutic Application - Cardiology, Oncology (Breast, Lung, Other Cancer Types), Neurology, Respiratory, Orthopedic, and Others
  • Modality - CT, MRI, X-Ray, Ultrasound, PET, Other Modalities
  • Workflow - Image Acquisition, Image Analysis, Detection, Diagnosis, and Treatment Decision Support, Predictive Analysis & Risk Assessment, Triage, Reporting and Communication, and Equipment Maintenance

Regional Segmentation

  • North America - U.S. and Canada
  • Europe - Germany, U.K, Italy, Spain, France, Switzerland, Sweden, Netherlands, and Rest of -Europe
  • Asia-Pacific - Japan, China, South Korea, Australia and New Zealand, Singapore, and Rest of -Asia -Pacific
  • Rest-of-the-World

Growth Drivers

  • Increasing Complexities of Clinical Decision -Making
  • Expanding Range of Applications
  • Shortage of Healthcare Workforce
  • Huge R&D investment

Market Challenges

  • Privacy and Security Concerns Related to Healthcare Data
  • Regulatory Challenges
  • Barriers to Physician’s Adoption of AI
  • Lag in Regulatory Approvals
  • Legal Implications of AI Systems
  • Rise in Medical Imaging Expenses
  • Data Security and Privacy Issues
  • Lack of Trained Staff

Market Opportunities

  • Rapidly Evolving Deep Learning Techniques
  • Increasing Number of Cross-Industry Partnerships

Key Companies Profiled

Siemens Healthineers AG., General Electric Company, Agfa - Gevart Group, Hologic, Inc., Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., Nuance Communications, Inc., Synopsys Inc., NVIDIA Corporation, Nanox, Butterfly Network, Inc., Hyperfine. Aidoc, Arterys Inc, Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, Envoy AI, MIRADA MEDICAL LIMITED, VUNO Inc., and Zebra Medical Vision, Inc.

Key Questions Answered in this Report:

  • What are the various AI-enabled medical imaging solutions and systems available in the market?
  • What is the current market size and future potential of these products?
  • What are the major market drivers, challenges, and opportunities in the global AI-enabled medical imaging solutions market?
  • What are the guidelines implemented by different government bodies to regulate the approval of AI-enabled medical imaging solutions?
  • What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
  • Who are the leading players holding dominating shares in the global AI-enabled medical imaging solutions market, currently?
  • What are the key strategies incorporated by the players of global AI-enabled medical imaging solutions market, to sustain the competition and retain their supremacy?
  • What is the current revenue contribution of different therapeutic applications, workflow, and modality, and how would it evolve in the forecast period?
  • What is the current demand contribution of different product types and how would it evolve in the forecast period?
  • What is the current demand contribution of different deployment models and how would it evolve in the forecast period?
  • Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global AI-enabled medical imaging solutions market?

Overview on the Global AI-Enabled Medical Imaging Solutions Market

Global AI-enabled imaging modalities market is currently witnessing a significant change in the market landscape. There is rising investment in development of healthcare infrastructure, increasing evidences for efficient and promising results in treatment and diagnosis assistance. Thus, this is leading to potential growth opportunities for the AI-enabled imaging modalities market. Moreover, there is an extensive entry of emerging players developing AI-powered imaging systems, and software companies into the healthcare space. All these predominant factors have led to a significant rise in sales of AI-based imaging modality systems across the globe.

Global AI-Enabled Medical Imaging Solutions Market Forecast, 2020-2030

The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020 -2030. The increasing complexities in clinical decision making, rising radiologist workload, and huge R&D investments are the major factors fueling market growth. In addition to these factors, there are significant challenges and restraints, which are restricting market growth. These challenges include the physicians’ reluctance toward the adoption of advanced technologies such as AI and the privacy and security concerns related to healthcare data. Hence, it is anticipated that these trends will have a significant impact on AI-enabled medical imaging solutions market in the next five years, and the market will grow multifold.

Competitive Landscape

The global AI-enabled medical imaging solutions market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of AI in healthcare, the manufacturers in the market have ample number of opportunities to expand their offerings and to establish a strong foothold in the market.

During January 2015 - November 2020, the market witnessed approximately 134 joint ventures, collaborations, and partnerships, 102 funding and investments, 101 product approvals, 54 product launches and enhancements, and six mergers and acquisitions in the past five years (2015 -2020). Joint ventures, collaborations, and partnerships were among the most frequently followed strategies which were incorporated by numerous players to establish a strong foothold in the market.

Most of the manufacturers in the market are incorporating collaborations and partnerships with not only other companies but also the university and research institutions as the key strategies to develop novel AI-embedded medical imaging systems and attain a strong financial position in the market.

Moreover, the leading imaging modality providers in the global AI-enabled medical imaging solutions market include Koninklijke Philips N.V., EchoNous, Inc., 4Dx Limited, Samsung Group, and Butterfly Network, Inc.

The leading platform providers, IT, and computing vendors in the global AI-enabled medical imaging solutions market include Intel Corporation, Blackford Analysis Limited, Synopsys, Inc., edgecase.ai, NTT Data Corporation, and EnvoyAI, among others.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agfa-Gevaert Group
  • Arterys Inc.
  • General Electric Company
  • Hyperfine
  • Koninklije Philips N.V.
  • Nanox
  • MORE

1 Product Definition

2 Research Scope

3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
3.3 Data Sources and Categorization
3.4 Criteria for Company Profiles
3.5 Market Estimation and Forecast Methodology
3.6 Data Triangulation
3.7 Assumptions and Limitations

4 Industry Insights
4.1 Industry Ecosystem
4.2 Legal Requirements and Regulations
4.2.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
4.2.1.1 Restraints in Current Regulatory Process for AI/ML-Based Medical Device/Algorithm
4.2.2 Regulatory Framework in the U.S.
4.2.3 Regulatory Framework in Europe
4.2.3.1 Changes in Rule
4.2.3.2 New Rules in the Annexure VIII
4.2.3.3 Major Changes in the EU due to the Implementation of MDR:
4.2.3.3.1 Expanded Device Definitions Requiring Re-Examination of the Current Classification of All Devices
4.2.3.3.2 Quality Management System
4.2.3.3.3 Technical File
4.2.3.3.4 Need to Comply with New Identification and Traceability (UDI) Requirements
4.2.3.3.5 More Emphasis on Post-Market Surveillance
4.2.3.3.6 Need for Strengthening the Role of Internal Audits and Mandatory Audits
4.2.3.3.7 Dedicated Personnel for MDR compliance
4.2.4 Regulatory Framework in Japan
4.2.5 Regulatory Framework in China
4.2.6 Regulatory Framework in Other Countries
4.2.6.1 Regulatory Framework in India
4.2.6.2 Regulatory Framework in Latin America
4.2.6.3 Regulatory Framework in the Middle East and Africa (MEA)
4.2.7 Consortiums, Associations, and Regulatory Bodies
4.3 Impact of COVID-19
4.3.1 Impact on Clinical Settings and Clinical Decision-Making
4.3.2 Impact on AI-Based Medical Imaging Solution Manufacturers
4.3.3 Conclusion

5 Real World Evidence
5.1 Overview
5.2 Aidoc
5.2.1 Role of Aidoc in the Global AI-Enabled Medical Imaging Solutions Market
5.3 Arterys Inc.
5.3.1 Role of Arterys Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.4 Bay Labs, Inc.
5.4.1 Role of Bay Labs, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.5 Heart Flow, Inc.
5.5.1 Role of Heart Flow, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.6 MIRADA MEDICAL LIMITED
5.6.1 Role of Mirada Medical Limited in the Global AI-Enabled Medical Imaging Solutions Market
5.7 RADLogics Inc.
5.7.1 Role of RADLogics Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.8 VIDA Diagnostics, Inc.
5.8.1 Role of VIDA Diagnostics, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.9 VUNO Inc.
5.9.1 Role of VUNO lnc. in the Global AI-Enabled Medical Imaging Solutions Market
5.1 Zebra Medical Vision, Inc.
5.10.1 Role of Zebra Medical Vision, Inc. in the Global AI-Enabled Medical Imaging Solutions Market

6 Global AI-Enabled Medical Imaging Solutions Market Scenario
6.1 Assumptions and Limitations
6.2 Global Market Scenario
6.3 Potential Market Opportunities
6.3.1 Rapidly Evolving Deep Learning Techniques
6.3.2 Increasing Number of Cross-Industry Partnerships
6.4 Market Dynamics
6.4.1 Impact Analysis
6.4.2 Market Drivers
6.4.2.1 Increasing Complexities of Clinical Decision-Making
6.4.2.2 Expanding Range of Applications
6.4.2.3 Shortage of Healthcare Workforce
6.4.2.4 Huge R&D Investments
6.4.3 Market Restraints
6.4.3.1 Privacy and Security Concerns Related to Healthcare Data
6.4.3.2 Regulatory Challenges
6.4.3.3 Barriers to Physician’s Adoption of AI
6.4.3.4 Lag in Regulatory Approvals
6.4.3.5 Legal Implications of AI Systems
6.4.3.6 Rise in Medical Imaging Expenses
6.4.3.7 Data Security and Privacy Issues
6.4.3.8 Lack of Trained Staff

7 Competitive Landscape
7.1 Key Strategies and Developments
7.1.1 Joint Ventures, Collaborations, and Partnerships
7.1.2 Funding and Investments
7.1.3 Regulatory and Legal Activities.
7.1.3.1 U.S. FDA Approvals
7.1.3.2 CE Mark Approvals
7.1.3.3 PMDA Approvals
7.1.3.4 Others
7.1.4 Product Launches and Enhancements
7.1.5 Mergers and Acquisitions
7.2 Growth Share Analysis
7.2.1 Growth Share Matrix (by Product)
7.2.2 Growth Share Matrix (by Workflow)
7.2.3 Growth Share Matrix (by Modality)

8 Global AI-Enabled Medical Imaging Solutions Market (by Modality)
8.1 Overview
8.2 Computed Tomography (CT)
8.3 Magnetic Resonance (MR)
8.4 Ultrasound
8.5 X-Ray
8.6 Mammography
8.7 Multimodality Imaging Systems
8.8 Other Modalities

9 Global AI-Enabled Medical Imaging Solutions Market (by Product)
9.1 Overview
9.2 Software
9.2.1 Perpetual Software License
9.2.2 Subscription Software License
9.2.3 Fee-Per Case Software License
9.3 Hardware

10 Global AI-Enabled Medical Imaging Solutions Market (by Deployment Model)
10.1 Overview
10.2 Cloud- and Web-Based Solutions
10.3 On-Premises Solutions

11 Global AI-Enabled Medical Imaging Solutions Market (by Workflow), 2019-2030
11.1 Overview
11.2 Image Acquisition
11.3 Image Analysis
11.4 Detection
11.5 Diagnosis and Treatment Decision Support
11.6 Predictive Analysis and Risk Assessment
11.7 Triage
11.8 Reporting and Communication

12 Global AI-Enabled Medical Imaging Solutions Market (by Therapeutic Application)
12.1 Overview
12.2 Specialty Imaging
12.2.1 Cardiology
12.2.2 Oncology
12.2.2.1 Lung Cancer
12.2.2.2 Breast Cancer
12.2.2.3 Other Cancer Types
12.2.3 Neurology
12.2.4 Respiratory
12.2.5 Orthopedics
12.2.6 Others
12.3 General Imaging

13 Global AI-Enabled Medical Imaging Solutions Market (by Region)
13.1 Overview
13.2 North America
13.2.1 Market Footprint: North America AI-Enabled Medical Imaging Solutions Market
13.2.2 North America AI-Enabled Medical Imaging Solutions Market (by Country)
13.2.2.1 U.S.
13.2.2.2 Canada
13.3 Europe
13.3.1 Market Footprint: Europe AI-Enabled Medical Imaging Solutions Market
13.3.2 Europe AI-Enabled Imaging Medical Imaging Solutions Market (by Country)
13.3.2.1 U.K.
13.3.2.2 Germany
13.3.2.3 France
13.3.2.4 Spain
13.3.2.5 Italy
13.3.2.6 Rest-of-Europe
13.3.2.7 Switzerland
13.3.2.8 Sweden
13.3.2.9 Netherlands
13.4 Asia-Pacific
13.4.1 Market Footprint: Asia-Pacific AI-Enabled Medical Imaging Solutions Market
13.4.2 Asia-Pacific AI-Enabled Medical Imaging Solutions Market (by Country)
13.4.2.1 China
13.4.2.2 Japan
13.4.2.3 Australia and New Zealand
13.4.2.4 South Korea
13.4.2.5 Singapore
13.4.2.6 Rest-of-Asia-Pacific
13.5 Rest-of-the-World (RoW)
13.5.1 Market Footprint: Rest-of-the-World AI-Enabled Medical Imaging Solutions Market

14 Company Profiles
14.1 Overview
14.2 Agfa-Gevaert Group
14.2.1 Company Overview
14.2.2 Role of Agfa-Gevaert Group in the Global AI-Enabled Medical Imaging Solutions Market
14.2.3 Financials
14.2.4 Agfa-Gevaert Group: SWOT Analysis
14.3 Butterfly Network, Inc.
14.3.1 Company Overview
14.3.2 Role of Butterfly Network, Inc. in the Global AI-Enabled Imaging Solutions Market
14.3.3 Butterfly Network, Inc.: SWOT Analysis
14.4 Fujifilm Holdings Corporation
14.4.1 Company Overview
14.4.2 Role of Fujifilm Holdings Corporation in the Global AI-Enabled Imaging Solutions Market
14.4.3 Financials
14.4.3.1 Key Insights About the Financial Health of the Company
14.4.4 Fujifilm Holdings Corporation: SWOT Analysis
14.5 General Electric Company
14.5.1 Company Overview
14.5.2 Role of General Electric Company in the Global AI-Enabled Medical Imaging Solutions Market
14.5.3 Financials
14.5.3.1 Key Insights About the Financial Health of the Company
14.5.4 General Electric Company: SWOT Analysis
14.6 Hyperfine
14.6.1 Company Overview
14.6.2 Role of Hyperfine in the Global AI-Enabled Imaging Solutions Market
14.6.3 Hyperfine: SWOT Analysis
14.7 Hologic, Inc.
14.7.1 Company Overview
14.7.2 Role of Hologic, Inc. in the Global AI-Enabled Imaging Solutions Market
14.7.3 Financials
14.7.4 Hologic, Inc.: SWOT Analysis
14.8 Koninklije Philips N.V.
14.8.1 Company Overview
14.8.2 Role of Koninklijke Philips N.V. in the Global AI-Enabled Imaging Solutions Market
14.8.3 Financials
14.8.3.1 Key Insights About the Financial Health of the Company
14.8.4 Koninklijke Philips N.V.: SWOT Analysis
14.9 Nanox
14.9.1 Company Overview
14.9.2 Role of Nanox in the Global AI-Enabled Medical Imaging Solutions Market
14.9.3 SWOT Analysis: Nanox
14.1 Siemens Healthineers AG
14.10.1 Company Overview
14.10.2 Role of Siemens Healthineers AG in the Global AI-Enabled Medical Imaging Solutions Market
14.10.3 Financials
14.10.3.1 Key Insights About the Financial Health of the Company
14.10.4 Siemens Healthineers AG: SWOT Analysis
14.11 Aidoc
14.11.1 Company Overview
14.11.2 Role of Aidoc in the Global AI-Enabled Medical Imaging Solutions Market
14.11.3 SWOT Analysis: Aidoc
14.12 Arterys Inc.
14.12.1 Company Overview
14.12.2 Role of Arterys Inc. in the Global AI-Enabled Medical Imaging Solutions Market
14.12.3 SWOT Analysis: Arterys Inc.
14.13 Beijing Infervision Technology Co., Ltd.
14.13.1 Company Overview
14.13.2 Role of Beijing Infervision Technology Co., Ltd. in the Global AI-Enabled Medical Imaging Solutions Market
14.13.3 SWOT Analysis: Beijing Infervision Technology Co., Ltd.
14.14 Blackford Analysis Limited
14.14.1 Company Overview
14.14.2 Role of Blackford Analysis Limited in the Global AI-Enabled Medical Imaging Solutions Market
14.14.3 SWOT Analysis: Blackford Analysis Limited
14.15 Eureka Clinical AI, formerly known as EnvoyAI
14.15.1 Company Overview
14.15.2 Role of Eureka Clinical AI, formerly known as EnvoyAI in the Global AI-Enabled Medical Imaging Solutions Market
14.15.3 SWOT Analysis: EnvoyAI
14.16 iCAD, Inc.
14.16.1 Company Overview
14.16.2 Role of iCAD, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
14.16.3 Financials
14.16.3.1 Key Insights About the Financial Health of the Company
14.16.4 iCAD, Inc.: SWOT Analysis
14.17 MIRADA MEDICAL LIMITED
14.17.1 Company Overview
14.17.2 Role of MIRADA MEDICAL LIMITED in the Global AI-Enabled Medical Imaging Solutions Market
14.17.3 SWOT Analysis: MIRADA MEDICAL LIMITED
14.18 Nuance Communications, Inc.
14.18.1 Company overview
14.18.2 Role of Nuance Communications, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
14.18.3 Financials
14.18.3.1 Key Insights About the Financial Health of the Company
14.18.4 Nuance Communications, Inc.: SWOT Analysis
14.19 NVIDIA Corporation
14.19.1 Company overview
14.19.2 Role of NVIDIA Corporation in the Global AI-Enabled Medical Imaging Solutions Market
14.19.3 Financials
14.19.3.1 Key Insights About the Financial Health of the Company
14.19.4 NVIDIA Corporation: SWOT Analysis
14.2 Synopsys, Inc.
14.20.1 Company Overview
14.20.2 Role of Synopsys, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
14.20.3 Financials
14.20.3.1 Key Insights About the Financial Health of the Company
14.20.4 Synopsys, Inc.: SWOT Analysis
14.21 VUNO lnc.
14.21.1 Company Overview
14.21.2 Role of VUNO lnc. in the Global AI-Enabled Medical Imaging Solutions Market
14.21.3 SWOT Analysis: VUNO lnc.
14.22 Zebra Medical Vision, Inc.
14.22.1 Company Overview
14.22.2 Role of Zebra Medical Vision, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
14.22.3 SWOT Analysis: Zebra Medical Vision, Inc.

List of Tables
Table 1: Market Drivers
Table 2: Market Restraints
Table 4.1: Database of the FDA-Approved AI/ML-Based Medical Devices and Algorithms
Table 4.2: List of Associations/Consortiums/Regulatory Bodies with Year of Establishment and Region
Table 5.1: Improvement in the RTAT of the Head and Neck CT Scans from Various Algorithms as Compared to the FIFO Concept
Table 5.2: Cost Comparison: Standard Care vs. VIDAvision
Table 6.1: Market Drivers
Table 6.2: Market Restraints
Table 7.1: List of FDA Approvals, January 2015-November 2020
Table 7.2: List of CE Mark Approvals, January 2015-November 2020
Table 7.3: List of Other Approvals, January 2015-November 2020
Table 8.1: List of Recently Approved AI-Enabled Mammography Solutions

List of Figures
Figure 1: Applications of AI in Healthcare
Figure 2: Share of Key Developments and Strategies, January 2015 - November 2020
Figure 3: Global AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 4: Global AI-Enabled Medical Imaging Solutions Market Share (by Product), 2019 and 2030
Figure 5: Global AI-Enabled Medical Imaging Solutions Market Share (by Workflow), 2019 and 2030
Figure 6: Global AI-Enabled Medical Imaging Solutions Market Share (by Therapeutic Application), 2019 and 2030
Figure 7: Global AI-Enabled Medical Imaging Solutions Market Share (by Deployment Model), 2019 and 2030
Figure 8: Global AI-Enabled Medical Imaging Solutions Market Share (by Modality), 2019 and 2030
Figure 9: Global AI-Enabled Medical Imaging Solutions Market Regional Snapshot, 2019 and 2030
Figure 2.1: Global AI-Enabled Medical Imaging Solutions Market Segmentation
Figure 3.1: Research Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Assumptions and Limitations
Figure 4.1: Industry Ecosystem
Figure 4.2: Regulatory Process for Medical Devices in the U.S.
Figure 4.3: MDR Transitional Provisions
Figure 4.4: MDR Timeline
Figure 5.1: Aidoc Product Offerings
Figure 5.2: Average RTAT for Positive Studies for AI-based Prioritized Queue and Baseline
Figure 5.3: Arterys Inc. Product Offerings
Figure 5.4: Cardiac Ejection Fraction Measurement: Conventional vs. CardioAI
Figure 5.5: Bay Labs, Inc. Product Offerings
Figure 5.6: Difference Between the Average Variability of the Cardiologists as Compared with the Variability of EchoMD AutoEF
Figure 5.7: Heart Flow, Inc. Product Offerings
Figure 5.8: Cost Reduction: Standard Treatment vs. HeartFlow FFRCT Analysis
Figure 5.9: Mirada Medical Limited Product Offerings
Figure 5.10: Comparison of DLCExpert Contours vs. Clinical Contours
Figure 5.11: RADLogics Inc. Product Offerings
Figure 5.12: Chest CT Time Reduction Using Virtual-Resident
Figure 5.13: VIDA Diagnostics Inc. Product Offerings
Figure 5.14: VUNO Inc. Product Offerings
Figure 5.15: Accuracy: BoneAge vs. Physician
Figure 5.16: Time: BoneAge vs. Physician
Figure 5.17: Zebra Medical Vision, Inc. Product Offerings
Figure 5.18: Algorithm-Radiologists Agreement as Compared to the Inter-Radiologists Agreement when the Algorithm Results are not Shown
Figure 5.19: Algorithm-Radiologists Agreement as Compared to the Inter-Radiologists Agreement when the Algorithm Results are Shown
Figure 6.1: Global AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 6.2: Top Ten Findings in Global AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 7.1: Share of Key Developments and Strategies, January 2015-November 2020
Figure 7.2: Share of Joint Ventures, Collaborations, and Partnerships, January 2015-November 2020
Figure 7.3: Major Joint Ventures, Collaborations, and Partnerships: General Electric Company
Figure 7.4: Major Joint Ventures, Collaborations, and Partnerships: Siemens Healthineers AG
Figure 7.5: Share of Product Launches and Enhancements, January 2015-November 2020
Figure 7.6: Share of Mergers and Acquisitions, January 2015-November 2020
Figure 7.7: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Product), 2019-2030
Figure 7.8: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Workflow), 2019-2030
Figure 7.9: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Modality), 2019-2030
Figure 8.1: Global AI-Enabled Medical Imaging Solutions Market (by Modality), 2019-2030
Figure 8.2: Global AI-Enabled Medical Imaging Solutions Market (CT), 2019-2030
Figure 8.3: Global AI- Medical Imaging Solutions Market (Magnetic Resonance), 2019-2030
Figure 8.4: Global AI-Enabled Medical Imaging Solutions Market (Ultrasound), 2019-2030
Figure 8.5: Global AI-Enabled Medical Imaging Solutions Market (X-Ray), $Million, 2019-2030
Figure 8.6: Global AI-Enabled Medical Imaging Solutions Market (Mammography), 2019-2030
Figure 8.7: Global AI-Enabled Medical Imaging Solutions Market (Multimodality Imaging Systems), 2019-2030
Figure 8.8: Global AI-Enabled Medical Imaging Solutions Market (Other Modalities), 2019-2030
Figure 9.1: Global AI-Enabled Medical Imaging Solutions Market (by Product), 2019-2030
Figure 9.2: Global AI-Enabled Medical Imaging Solutions Market (by Software), 2019-2030
Figure 9.3: Global AI-Enabled Medical Imaging Solutions Market (Perpetual Software License), 2019-2030
Figure 9.4: Global AI-Enabled Medical Imaging Solutions Market (Subscription Software License), 2019-2030
Figure 9.5: Global AI-Enabled Medical Imaging Solutions Market (Fee-Per Case Software License), 2019-2030
Figure 9.6: Global AI-Enabled Medical Imaging Solutions Market (Hardware), 2019-2030
Figure 10.1: Global AI-Enabled Medical Imaging Solutions Market (by Deployment Model), 2019-2030
Figure 10.2: Global AI-Enabled Medical Imaging Solutions Market (by Cloud and Web-Based Solutions), 2019-2030
Figure 10.3: Global AI-Enabled Medical Imaging Solutions Market (by On-Premises Solutions), 2019-2030
Figure 11.1: Global AI-Enabled Medical Imaging Solutions Market (Image Acquisition), 2019-2030
Figure 11.2: Global AI-Enabled Medical Imaging Solutions Market (Image Analysis), 2019-2030
Figure 11.3: Global AI-Enabled Medical Imaging Solutions Market (Detection), 2019-2030
Figure 11.4: Global AI-Enabled Medical Imaging Solutions Market (Diagnosis and Treatment Decision Support), 2019-2030
Figure 11.5: Global AI-Enabled Medical Imaging Solutions Market (Predictive Analysis and Risk Assessment), 2019-2030
Figure 11.6: Global AI-Enabled Medical Imaging Solutions Market (Triage), 2019-2030
Figure 11.7: Global AI-Enabled Medical Imaging Solutions Market (Reporting and Communication), 2019-2030
Figure 12.1: Global AI-Enabled Medical Imaging Solutions Market (by Therapeutic Application), 2019-2030
Figure 12.2: Global AI-Enabled Medical Imaging Solutions Market (Specialty Imaging), 2019-2030
Figure 12.3: Global AI-Enabled Medical Imaging Solutions Market (Cardiology), 2019-2030
Figure 12.4: Applications of AI in Cancer Imaging
Figure 12.5: Global AI-Enabled Medical Imaging Solutions Market (Oncology), 2019-2030
Figure 12.6: Global AI-Enabled Medical Imaging Solutions Market (Lung Cancer), 2019-2030
Figure 12.7: Global AI-Enabled Medical Imaging Solutions Market (Breast Cancer), 2019-2030
Figure 12.8: Global AI-Enabled Medical Imaging Solutions Market (by Other Cancer Types), 2019-2030
Figure 12.9: Global AI-Enabled Medical Imaging Solutions Market (Neurology), 2019-2030
Figure 12.10: Global AI-Enabled Medical Imaging Solutions Market (Respiratory), 2019-2030
Figure 12.11: Global AI-Enabled Medical Imaging Solutions Market (Orthopedics), 2019-2030
Figure 12.12: Global AI-Enabled Medical Imaging Solutions Market (Others), 2019-2030
Figure 12.13: Global AI-Enabled Medical Imaging Solutions Market (General Imaging), 2019-2030
Figure 13.1: Global AI-Enabled Medical Imaging Solutions Market Scenario, 2019 and 2030
Figure 13.2: North America AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.3: North America AI-Enabled Medical Imaging Solutions Market: Market Dynamics
Figure 13.4: North America AI-Enabled Medical Imaging Solutions Market (by Country), 2019-2030
Figure 13.5: U.S. AI-Enabled Imaging Medical Imaging Solutions Market, 2019-2030
Figure 13.6: Canada AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.7: Europe AI-Enabled Imaging Medical Imaging Solutions Market, 2019-2030
Figure 13.8: Europe AI-Enabled Medical Imaging Solutions Market: Market Dynamics
Figure 13.9: Europe AI-Enabled Medical Imaging Solutions Market (by Country), 2019-2030
Figure 13.10: U.K. AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.11: Germany AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.12: France AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.13: Spain AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.14: Italy AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.15: Rest-of-Europe AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.16: Switzerland AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.17: Sweden AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.18: Netherlands AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.19: Asia-Pacific AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.20: Asia-Pacific AI-Enabled Medical Imaging Solutions Market: Market Dynamics
Figure 13.21: Asia-Pacific AI-Enabled Medical Imaging Solutions Market (by Country), 2019-2030
Figure 13.22: China AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.23: Japan AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.24: Australia and New Zealand AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.25: South Korea AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.26: Singapore AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.27: Rest-of-Asia-Pacific AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 13.28: Rest-of-the-World AI-Enabled Medical Imaging Solutions Market, 2019-2030
Figure 14.1: Shares of Key Company Profiles
Figure 14.2: Agfa-Gevaert Group: Product Offerings for the Global AI-Enabled Imaging Solutions Market
Figure 14.3: Agfa-Gevaert Group: Overall Financials, 2017-2019
Figure 14.4: Agfa-Gevaert Group: Net Revenue (by Business Segment), 2017-2019
Figure 14.5: Agfa-Gevaert Group: Revenue (by Region), 2017-2019
Figure 14.6: Agfa-Gevaert Group: R&D Expenditure, 2017-2019
Figure 14.7: Butterfly Network, Inc.: Product Offerings for the Global AI-Enabled Imaging Solutions Market
Figure 14.8: Fujifilm Holdings Corporation: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.9: Fujifilm Holdings Corporation: Overall Financials, 2017-2019
Figure 14.10: Fujifilm Holdings Corporation Net Revenue (by Business Segment), 2017-2019
Figure 14.11: Fujifilm Holdings Corporation: Net Revenue (by Region), 2016-2018
Figure 14.12: Fujifilm Holdings Corporation: R&D Expense, 2017-2019
Figure 14.13: General Electric Company: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.14: General Electric Company: Overall Financials, 2017-2019
Figure 14.15: General Electric Company Net Revenue (by Business Segment), 2017-2019
Figure 14.16: General Electric Company: Net Revenue (by Region), 2017-2019
Figure 14.17: General Electric Company: R&D Expenditure, 2017-2019
Figure 14.18: Hyperfine: Product Offerings for the AI-Enabled Imaging Solutions Market
Figure 14.19: Hologic, Inc.: Product Offerings for the AI-Enabled Imaging Solutions Market
Figure 14.20: Hologic, Inc.: Overall Financials, 2017-2019
Figure 14.21: Hologic, Inc.: Net Revenue (by Business Segment), 2017-2019
Figure 14.22: Hologic, Inc.: Revenue (by Region), 2017-2019
Figure 14.23: Hologic, Inc.: R&D Expenditure, 2017-2019
Figure 14.24: Koninklijke Philips N.V.: Product Offerings for the Global AI-Enabled Imaging Solutions Market
Figure 14.25: Koninklijke Philips N.V.: Overall Financials, 2017-2019
Figure 14.26: Koninklijke Philips N.V. Net Revenue (by Business Segment), 2017-2019
Figure 14.27: Koninklijke Philips N.V.: Net Revenue (by Region), 2017-2019
Figure 14.28: Koninklijke Philips N.V.: R&D Expenditure, 2017-2019
Figure 14.29: Nanox: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.30: Siemens Healthineers AG: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.31: Siemens Healthineers AG: Overall Financials, 2018-2020
Figure 14.32: Siemens Healthineers AG Net Revenue (by Business Segment), 2018-2020
Figure 14.33: Siemens Healthineers AG: Net Revenue (by Region), 2018-2020
Figure 14.34: Siemens Healthineers AG: R&D Expenditure, 2018-2020
Figure 14.35: Aidoc: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.36: Arterys Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.37: Beijing Infervision Technology Co., Ltd.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.38: Blackford Analysis Limited: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.39: EnvoyAI: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.40: iCAD, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.41: iCAD, Inc.: Overall Financials, 2017-2019
Figure 14.42: iCAD, Inc. Net Revenue (by Business Segment), 2017-2019
Figure 14.43: iCAD, Inc.: R&D Expense, 2017-2019
Figure 14.44: MIRADA MEDICAL LIMITED: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.45: Nuance Communications, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.46: Nuance Communications, Inc.: Overall Financials, 2018-2020
Figure 14.47: Nuance Communications, Inc. Net Revenue (by Business Segment), 2018-2020
Figure 14.48: Nuance Communications, Inc.: R&D Expense, 2018-2020
Figure 14.49: NVIDIA Corporation: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.50: NVIDIA Corporation: Overall Financials, 2017-2019
Figure 14.51: NVIDIA Corporation Net Revenue (by Business Segment), 2017-2019
Figure 14.52: NVIDIA Corporation: Net Revenue (by Region), 2017-2019
Figure 14.53: NVIDIA Corporation: R&D Expense, 2017-2019
Figure 14.54: Synopsys, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.55: Synopsys, Inc.: Overall Financials, 2018-2020
Figure 14.56: Synopsys, Inc.: Net Revenue (by Region), 2018-2020
Figure 14.57: Synopsys, Inc.: R&D Expense, 2018-2020
Figure 14.58: VUNO lnc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
Figure 14.59: Zebra Medical Vision, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market

Note: Product cover images may vary from those shown

Loading
LOADING...

  • Agfa-Gevaert Group
  • Aidoc
  • Arterys Inc.
  • Beijing Infervision Technology Co., Ltd.
  • Blackford Analysis Limited
  • Butterfly Network, Inc.
  • Eureka Clinical AI, formerly known as EnvoyAI
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hologic, Inc.
  • Hyperfine
  • iCAD, Inc.
  • Koninklije Philips N.V.
  • MIRADA MEDICAL LIMITED
  • Nanox
  • Nuance Communications, Inc.
  • NVIDIA Corporation
  • Siemens Healthineers AG
  • Synopsys, Inc.
  • VUNO lnc.
  • Zebra Medical Vision, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll